MELBOURNE, Australia and LIÈGE, Belgium, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has entered into an agreement with Curium Pharma for the transfer of marketing and distribution rights for Scintimun®...
Hence then, the article about scintimun commercialization partnership with curium pharma was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Scintimun® Commercialization Partnership with Curium Pharma )
Also on site :
- Meta lines up layoffs while Microsoft offers buyouts
- Meta Prepares 8,000 Layoffs to Offset AI Infrastructure Investments .. PYMNTS.com
- Ella Langley Is Hosting 'Dinner at the Opry' — Here's How You Can Grab a Seat